Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veg of Lund AB - Interim report Q2 2023

Increased sales at lower costApril–June 2023 · Net sales amounted to TSEK 1,4580 (1 070). · Operating profit before depreciation and amortization (EBITDA) amounted to TSEK-7,824 (-11,291), and EBIT amounted to TSEK -7,842 (-11,343). · Net profit amounted to TSEK -8,069 (-11,183). January–June 2023 · Net sales amounted to TSEK 3,281 (1 524). · Operating profit before depreciation and amortization (EBITDA) amounted to TSEK-16,102 (-29,004), and EBIT amounted to TSEK -16,173 (-29,107). · Net profit amounted to TSEK -16,687 (-29,182). Summary of the Group’s

Promising tumor control for fostrox in combination with Lenvima in ongoing phase 2a study in HCC, 15th patient included

· Continued tumor control in the liver in 7 of the first 10 patients after three months of treatment · The patient who benefited the longest from fostrox + Lenvima® remains on treatment after 12 months, with tumor reduction maintained · Consistently good safety and tolerability profile Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the 15th patient with advanced hepatocellular carcinoma (HCC) has been included in the ongoing phase 2a

Notice of extra general meeting in FlexQube AB (publ)

The shareholders of FlexQube AB (publ), reg. no. 556905-3944, (the "Company") are hereby invited to the extra general meeting to be held on Wednesday 30 August 2023, at 14:00 CET in the Company’s premises at Neongatan 8, 431 53 in Mölndal. Right to attend the general meeting Shareholders wishing to attend the extra general meeting must: i. on the record date, which is Tuesday 22 August 2023, be registered in the share register maintained by Euroclear Sweden AB; and ii. notify their participation at the general meeting no later than Thursday 24 August 2023. Notice of

Biosergen publishes interim report for first quarter 2023

Monday, August 14, 2023: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the second quarter 2023. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q2 2023 2023 2022 2023 2022 2022TSEK April-June April-June Jan-June Jan-June Jan-Dec Profit/loss Other income 2.456 1.409 7.771 2.726 5.183Profit/loss before -8.038 -7.963 -13.067 -12.981 -34.

XNK Therapeutics to present two posters at the NK2023 conference in Oslo in September

XNK Therapeutics AB today announced that two posters, regarding bladder cancer and Acute Myeloid Leukemia (AML) respectively, will be presented at the 20[th] Meeting of the Society for Natural Immunity (NK2023) in Oslo, Norway, in September.XNK Therapeutics will participate at NK2023 in Oslo in September and present the latest research relating to the company’s leading natural killer (NK) cells therapies. Two abstracts have been accepted for presentation at the meeting. The data have been generated in collaboration with XNK’s external partners, Anders Ullén and Fernanda Costa Svedman at

The Board of Directors in FlexQube intends to resolve a fully guaranteed rights issue of approximately 75MSEK and explore the conditions to carry out directed share issue of approximately 25MSEK

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES PURSUANT TO APPLICABLE LAW. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Mölndal, August 14, 2023 The Board of Directors in FlexQube intends to resolve on a fully guaranteed

Elkem ASA - Initiation of a share buyback

Oslo, 14 August 2023 Elkem ASA ("Elkem" or the "Company") has decided to initiate a buyback of up to 2 million of its own shares. The shares will be used as settlement in the Company's share-based incentive scheme. The buybacks will be made in accordance with the authorisation granted to the board of directors by the Company's annual general meeting held on 28 April 2023. According to the authorisation, shares up to 10% of the share capital may be purchased at a minimum of NOK 1 and a maximum of NOK 150 per share. The authorisation is valid until the annual general meeting in 2024.

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q2 2023 results

2020 Bulkers Ltd. will release its financial results for the second quarter of 2023 on Wednesday, August 16, 2023. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://channel.royalcast.com/landingpage/hegnarmedia/20230816_2/ or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/

AcuCort joins Röda webben ahead of commercialization

AcuCort has joined the Röda webben services which is coordinated by the industry organization for pharmaceutical companies conducting research - LIF. The affiliation is a step towards the upcoming commercialization of the company's pharmaceutical product Zeqmelit®.Within the pharmaceutical industry, there are elaborate complaint and recall procedures. The guidelines are collected on the so-called Röda webben and describe how complaints and withdrawals of medicines should be handled in Sweden. These guidelines constitute standards for the pharmaceutical industry with products on the Swedish

NAGRA selects Reltime to enable a Super App Wallet and Digital services for Telecom operators globally

Oslo, Norway – 14 August 2023 - Reltime, an award-winning provider of next-generation Web3 platform and services has today announced an agreement with NAGRA, the digital TV division of the Kudelski Group, to enable Super Apps through a non-custodian wallet and digital services for Telecom operators globally. NAGRA is the world’s leading independent provider of content protection and multiscreen solutions for the media and entertainment industry with over 550 customers (serving over 400m subscribers) globally. The NAGRA and Reltime partnership represents a ground-breaking

Repurchases of shares by EQT AB during week 32, 2023

Between 7 August 2023 and 11 August 2023 EQT AB (LEI code 213800U7P9GOIRKCTB34) (“EQT”) has repurchased in total 393,926 own ordinary shares (ISIN: SE0012853455) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 1,800,000 own ordinary shares for a total maximum amount of SEK 500,000,000 that EQT announced on 14 July 2023. The repurchase program, which runs between 17 July 2023 and 25 August 2023, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Changes in Bittium Corporation’s Management Group

Bittium CorporationChanges board/management/auditors Changes in Bittium Corporation’s Management Group Bittium Corporation, Stock Exchange Release, August 14, 2023, at 8.45 am (CEST+1) Jari Sankala, Senior Vice President, Defense & Security Business Unit of Bittium Corporation, and member of Bittium Corporation's management group, has decided to leave the company and continue his career outside of Bittium. Sankala will continue to work for the Company until February 14, 2024, acting as Advisor for the Defense & Security business to facilitate a smooth transition. Tommi Kangas (

Eevia Health Plc receiveS A 473k sek (42K USD) sales order for Feno-Sambucus™ 7 Organic.

Eevia Health ("Eevia" or "The Company") received a 473K SEK / 42K USD sales order for the elderberry extract Feno-Sambucus™ 7 Organic from a distributor in the US.The order is from Select Ingredients, a distributor located in San Diego, California, US. Select Ingredients is a specialist in organic ingredients and high-quality natural plant extracts, serving branded customers in the Golden State and other large states in the US. The end customer is a brand owner that specializes in organic plant-based food supplements without sugars and artificial compounds. The end customer provides

Kesko’s sales in July

Kesko Group’s sales in July 2023 totalled €908.8 million, representing a decrease of 1.3%.”Sales in July grew in all grocery trade division businesses. Sales grew also in the car trade division in all car trade business areas. In the building and technical trade division, sales decreased as construction activity weakened, says Mikko Helander, Kesko’s President and CEO. Sales in the grocery trade division totalled €513.1 million in July, an increase of 1.7%. Grocery sales to K Group grocery stores increased by 1.3%. Sales grew in K-Citymarket’s home and speciality goods (non-food). Kespro’

Study: concern over climate change influences city-dwellers’ choices at home

YIT Corporation Press release 14 August 2023 at 7:00 a.m.According to a barometer* commissioned by YIT, half (50%) of the residents living in larger cities keep themselves up to date of their carbon footprint and continuously take environmental actions to reduce their carbon footprint. One-third (38%) of the respondents are not interested in looking for information about the topic themselves, but wish to receive tips and guidance for actions. Slightly over one-tenth are not interested in the topic. Concern over climate change already influences many city-dwellers’ choices at home. For

Zoran Jankulovski appointed as new COO of Allgon

Allgon, a leading player in the market of innovative wireless communication solutions, is pleased to announce the appointment of Mr. Zoran Jankulovski as its new Chief Operating Officer (COO) – an experienced and senior business executive with a long and successful career in SKF and General Electric. With his extensive experience in running global organizations in different segments and a proven track record of delivering sustainable results, Zoran Jankulovski will play a crucial role in spearheading the company's growth strategy and operational excellence worldwide.‘’Allgon harbors

Gardening – 10 Jobs to Complete In August

It's official – August is here, the kids are off school, and it's the best time of the year to make the most of your garden. To keep your garden looking in top form right through to Autumn, there are several jobs that you need to complete now.   [A pair of scissors on grass Description automatically generated]   In August, watering is one of the most important things you can do in the garden. In addition, you’ll need to keep an eye on how your plants are handling the hot weather. Towards the end of the month, it’s time to start preparing your garden for the colder weather to

DecideAct H1 Report 2023: 16% growth in customer base since June 2022 and fit and proper to reach break-even in 2024.

DecideAct A/S [ACT]Company Announcement No. 13-2023:NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN12 AUGUST 2023 DecideAct’s half-year Report for the period 1 January to 30 June 2023, was approved by the Board of Directors today. The Report is attached to this release and can be read here: https://www.decideact.net/investor-relations/On 30 June 2023, DecideAct reached a growth in ARR before churn of 22% (YOY) and an ARR of DKK 10 million. Like other SaaS companies, DecideAct has been affected by companies taking a step back and cutting their fixed costs. Despite these extraordinary

Notice to attend the extraordinary general meeting of Elos Medtech AB (publ)

The shareholders of Elos Medtech AB (publ), reg. no. 556021-9650, headquartered in Gothenburg (“Elos Medtech” or the “Company”), are hereby invited to the extraordinary general meeting (the “EGM”) on Friday, 15 September 2023. The EGM will be held at 14:00 at Torsgatan 5B, 411 04 Gothenburg, Sweden. The meeting venue will open at 13:00 for registration. Registration of participants at the meeting ends when the meeting is called to order. Right to participation Shareholders who wish to participate in the proceedings of the EGM must: · be registered as shareholders in the register

Elos Medtech resolves on rights issue subject to approval of the general meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER REGISTRATION MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. Elos Medtech AB (publ) (“Elos Medtech” or the “Company”), today announces that the board of directors has decided to carry out a new issue of shares

Africa Energy Announces Second Quarter 2023 Results

VANCOUVER, BC, Aug. 11, 2023 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas exploration company, announces financial and operating results for the three and six months ended June 30, 2023.   OUTLOOK  The Block 11B/12B[1] joint venture has applied for the Production Right and is contemplating an early production system (“EPS”) for a phased development of the Paddavissie Fairway. The EPS would provide first gas and condensate production from the Luiperd discovery and would accelerate the Block 11B/12B

Nordea Bank Abp: Repurchase of own shares on 11.08.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares11.08.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 11.08.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |43,647 |10.30 |449,664.49

Debt Financing Update

("Amaroq" or the "Corporation" or the "Company") Debt Financing Update TORONTO, ONTARIO - August 11, 2023 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ) provides an update on its debt financing, announced on March 28, 2023. Amaroq continues to finalise the terms and conditions of the debt financing and expects to close the transaction by the end of August 2023. The debt financing consists of an increased US$50.9 million senior secured package, including: (i)         US$18.5 million in senior debt term loans pursuant to revolving credit facilities provided by

There are no items matching the current filter
There are no more items matching the current filter
Back to top